Table 1.
Demographic information and sample data for oropharyngeal (A) and oral tongue (B) samples. In one sample sex data was not obtaineda, Excluded from experimentationb BOT—base of tongue, NOS—not otherwise specified, SCC—squamous cell carcinoma, IHC—immunohistochemistry, PCR— polymerization chain reaction.
| A | |
| Oropharynx (n = 30) | |
| Sex% (n)a | |
| Male | 44.8 (13) |
| Female | 55.2 (16) |
| Avg. Age (Std dev) | 59.3 (14.2) |
| Location% (n) | |
| Tonsil | 23.3 (7) |
| BOT | 16.7 (5) |
| Palate | 6.7 (2) |
| Pharyngeal Wall | 3.3 (1) |
| Oropharynx NOS | 50 (15) |
| Pathology% (n) | |
| SCC | 73.3 (22) |
| SCC—Keratinizing | 81.8 (18) |
| Other (Not SCC)b | 26.7 (8) |
| p16 IHC% (n) | |
| Positive | 0 (0) |
| PCR HPV-16 E6/ E7 % (n) | |
| Positive | 0 (0) |
| B | |
| Oral Tongue (n = 31) | |
| Sex% (n)a | |
| Male | 67.8 (21) |
| Female | 32.2 (10) |
| Avg. Age (Std dev) | 51.8 (15.8) |
| Pathology% (n) | |
| SCC | 93.5 (29) |
| SCC—Keratinizing | 72.4 (21) |
| Other (Not SCC)b | 6.5 (2) |
| p16 IHC% (n) | |
| Positive | 6.9 (2) |
| PCR HPV-16 E6/E7 % (n) | |
| Positive | 0 (0) |
a
one sex missing.
b
Excluded from experimentation.